Cormark Has Bearish Forecast for BNS FY2025 Earnings

The Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) – Equities researchers at Cormark reduced their FY2025 earnings estimates for shares of Bank of Nova Scotia in a research report issued on Wednesday, December 4th. Cormark analyst L. Persaud now forecasts that the bank will post earnings of $4.94 per share for the year, down from their previous estimate of $5.08. The consensus estimate for Bank of Nova Scotia’s current full-year earnings is $5.06 per share. Cormark also issued estimates for Bank of Nova Scotia’s FY2026 earnings at $5.67 EPS.

Several other brokerages also recently commented on BNS. Canaccord Genuity Group upgraded shares of Bank of Nova Scotia from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Canaccord Genuity Group upgraded shares of Bank of Nova Scotia from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. UBS Group upgraded shares of Bank of Nova Scotia from a “neutral” rating to a “buy” rating in a report on Monday, November 18th. Cibc World Mkts upgraded shares of Bank of Nova Scotia from a “hold” rating to a “strong-buy” rating in a report on Friday, September 20th. Finally, Royal Bank of Canada lifted their target price on shares of Bank of Nova Scotia from $65.00 to $74.00 and gave the stock a “sector perform” rating in a report on Wednesday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $72.00.

Bank of Nova Scotia Price Performance

BNS stock opened at $55.79 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.61. Bank of Nova Scotia has a 1 year low of $43.67 and a 1 year high of $57.07. The company has a fifty day simple moving average of $53.90 and a 200 day simple moving average of $49.92. The firm has a market cap of $69.42 billion, a PE ratio of 12.91, a PEG ratio of 1.41 and a beta of 1.07.

Institutional Trading of Bank of Nova Scotia

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Mather Group LLC. increased its stake in Bank of Nova Scotia by 1,388.9% in the second quarter. Mather Group LLC. now owns 536 shares of the bank’s stock valued at $25,000 after acquiring an additional 500 shares during the period. Blue Trust Inc. boosted its position in Bank of Nova Scotia by 3,127.8% in the second quarter. Blue Trust Inc. now owns 581 shares of the bank’s stock valued at $27,000 after buying an additional 563 shares in the last quarter. BNP Paribas Financial Markets boosted its position in Bank of Nova Scotia by 1,588.2% in the third quarter. BNP Paribas Financial Markets now owns 861 shares of the bank’s stock valued at $47,000 after buying an additional 810 shares in the last quarter. City State Bank acquired a new position in Bank of Nova Scotia in the third quarter valued at about $57,000. Finally, Ashton Thomas Private Wealth LLC acquired a new position in Bank of Nova Scotia in the second quarter valued at about $104,000. Institutional investors own 49.13% of the company’s stock.

Bank of Nova Scotia Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, January 7th will be paid a $0.7535 dividend. The ex-dividend date of this dividend is Tuesday, January 7th. This represents a $3.01 dividend on an annualized basis and a yield of 5.40%. Bank of Nova Scotia’s payout ratio is currently 72.45%.

Bank of Nova Scotia Company Profile

The Bank of Nova Scotia provides various banking products and services in Canada, the United States, Mexico, Peru, Chile, Colombia, the Caribbean and Central America, and internationally. It operates through Canadian Banking, International Banking, Global Wealth Management, and Global Banking and Markets segments.